
Washington DC: According to a groundbreaking study conducted by Case Western Reserve University researchers, a class of drugs used to treat type 2 diabetes may also reduce the risk of colorectal cancer (CRC).

Washington DC: According to a groundbreaking study conducted by Case Western Reserve University researchers, a class of drugs used to treat type 2 diabetes may also reduce the risk of colorectal cancer (CRC).